gentamicin has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Lymphoma, B-Cell, Marginal Zone: Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margat, E | 1 |
| Dargère, S | 1 |
| Daurel, C | 1 |
| Fines-Guyon, M | 1 |
| Michon, J | 1 |
| Verdon, R | 1 |
| Cattoir, V | 1 |
1 other study available for gentamicin and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Communit | 2013 |